Sugar stocks down; EID Parry stocks marginally up

Major sugar stocks, specifically those above Rs 1000 crore market-cap, have lost their sweetness in intraday trade on January 18, 2017. However, EID Parry is trading up with 0.6% gains at 281 levels. Bannariamman Sugars has dropped 3% at 2037 levels; while Balrampur Chini has fallen 1% and more, standing at 140 levels.

Other stocks that have tumbled more than 1% are Triveni Engineering and Industries, Shree Renuka and Dhampur Sugar. Bajaj Hind and Dalmia Sugar remained marginally down. Most of the stocks have entered their profit booking zones after rallying up to their 52 week highs, post the government mulling that it may drop the plan of reduction of import duty on sugar.

Furthermore,EID Parry has also been struggling to maintain optimism with tremendous intraday volatility. On a daily basis the stock has been trading in consolidation from the last four trading sessions. The stock may see a positive rally again above 283-284 levels.

By ForexTime
Three signs of market chaos
Professional forex traders are well aware of the risks involved in trading currencies and the events of the last few years have only heightened that awareness. We all remember the carnage of 2008 and the volatility that was seen across nearly every asset class available.
However, while risk is always at the forefront of a traders mind, the fact is that markets actually trade in a very sensible and organised fashion for the majority of the time. The trouble is, that those few days/ weeks of volatility, can be so severe that they can destroy months of hard work in a very short space of time.
With that in mind, it's important for traders to choose a reputable ...

Asia-Pacific Pre-Primary Education and Childcare Industry Outlook to 2017- India and China to Lead Growth” presents a comprehensive analysis of the industry covering aspects including market size in terms of enrollments and establishments. The report also entails a detailed description of the prominent and emerging geographic markets of the region including India, China, Japan, South Korea and Australia.
South and West Asian regions have witnessed the emergence of a burgeoning pre-primary education and childcare industry in the span of the last ten years. The gross enrollment ratios have shown a tremendous improvement from a growing number of children taking part in the preschool programs or receiving child care benefits. As ...

MARKET UPDATE
Equity benchmarks continued their positive performance, with the Nifty opening at a fresh record high of on Thursday. Indices opened comfortably above their new milestones.
The Sensex was up 52.38 points at 30300.55, while the Nifty was up 26.10 points at 9433.40. the market breadth was healthy as 629 shares advanced against a decline of 172 shares, while 45 shares were unchanged.
Midcaps and banks gained around half a percent, along with the IT index.
Mahindra & Mahindra, Tata Steel, Hindalco and Zee Entertainment were the top gainers, while Bharti Airtel and HUL lost the most.
HCL Technologies was up over 1 percent following its better than expected Q4 results, while Zee ...

The Monsoons, an approaching El Nino are the key components to observe inthe Indian agri markets. The Oil seeds complex will be impacted by Indonesia's fare obligation on CPO and Brazil's Soy Crop information.
India has gotten 5% more precipitation than as far as possible as ofrecently even as northwest India, the southern landmass and Central India have gotten underneath typical precipitation – according to IMD.
GET MORE:
MCX LIVE TODAY
FREE TRIAL

Recent Forum Posts

Shares of Aurobindo Pharma rose nearly 2% after the company rece... moreShares of Aurobindo Pharma rose nearly 2% after the company received the US Food and Drug Administration's approval for efavirenz capsule, a generic of Sustiva, which is marketed by Bristol-Myers Squibb.
The drug is used to prevent human immunodeficiency virus from multiplying. The company has also received tentative approval from the US drug regulator for omeprazole magnesium tablet, used in the treatment of symptoms of gastroesophageal reflux disease and other conditions caused by excess stomach acid.
This approval of drug gives Aurobindo scope of growth in US generic business. This will strengthen the US product portfolio and will increase its market share. less

Our Services

Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this site are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither ValueNotes nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.